Relevant bibliographies by topics / Radiotherapy and Nuclear Medicine

Academic literature on the topic 'Radiotherapy and Nuclear Medicine'

Author: Grafiati
Published: 4 June 2021
Last updated: 8 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Contents

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Radiotherapy and Nuclear Medicine.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Radiotherapy and Nuclear Medicine"

1

Alashban, Yazeed, and Nasser Shubayr. "OCCUPATIONAL DOSE ASSESSMENT FOR NUCLEAR MEDICINE AND RADIOTHERAPY TECHNOLOGISTS IN SAUDI ARABIA." Radiation Protection Dosimetry 195, no. 1 (June 2021): 50–55. http://dx.doi.org/10.1093/rpd/ncab112.

Full text
Abstract:
Abstract This study estimated the occupational radiation dose received by nuclear medicine and radiotherapy technologists in Saudi Arabia. A retrospective analysis of personal dosemetry data of 1243 nuclear medicine and radiotherapy technologists from 28 medical centers across Saudi Arabia from 2015 to 2019 was conducted. Thermoluminescent dosemeters were employed to monitor the occupational radiation dose. For the study period, the average annual values for nuclear medicine and radiotherapy technologists were found to be 1.22 mSv (SD = 1.00 mSv) and 0.73 mSv (SD = 0.40 mSv) for Hp(10) and 1.23 mSv (SD = 1.07 mSv) and 0.72 mSv (SD = 0.41 mSv) for Hp(0.07), respectively. The work routines of nuclear medicine technologists cause them to be exposed to higher radiation doses than radiotherapy technologists. The occupational doses for all technologists were found to be below the annual dose limits, which indicates satisfactory working conditions in terms of radiation protection.
APA, Harvard, Vancouver, ISO, and other styles
2

Wu, Sing-yung, and George Juler. "Thyroid Disease: Endocrinology, Surgery, Nuclear Medicine, and Radiotherapy." Thyroid 1, no. 4 (January 1991): 369. http://dx.doi.org/10.1089/thy.1991.1.369.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Gharib, Hossein. "Thyroid Disease: Endocrinology, Surgery, Nuclear Medicine, and Radiotherapy." Mayo Clinic Proceedings 66, no. 2 (February 1991): 226–27. http://dx.doi.org/10.1016/s0025-6196(12)60503-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

&NA;. "Thyroid Disease. Endocrinology, Surgery, Nuclear Medicine, and Radiotherapy." Endocrinologist 8, no. 3 (May 1998): 229–30. http://dx.doi.org/10.1097/00019616-199805000-00016.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Stoffer, Sheldon S. "Thyroid Disease: Endocrinology, Surgery, Nuclear Medicine, and Radiotherapy." JAMA: The Journal of the American Medical Association 265, no. 13 (April 3, 1991): 1741. http://dx.doi.org/10.1001/jama.1991.03460130133037.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Mountz, James M. "Thyroid Disease, Endocrinology, Surgery, Nuclear Medicine and Radiotherapy." Clinical Nuclear Medicine 16, no. 11 (November 1991): 878. http://dx.doi.org/10.1097/00003072-199111000-00024.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Volpé, Robert. "Thyroid disease: Endocrinology, surgery, nuclear medicine and radiotherapy." Trends in Endocrinology & Metabolism 3, no. 1 (January 1992): 38. http://dx.doi.org/10.1016/1043-2760(92)90093-g.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

GURLL, NELSON. "Thyroid Disease: Endocrinology, Surgery, Nuclear Medicine, Radiotherapy, Second Edition." Annals of Surgery 229, no. 3 (March 1999): 440. http://dx.doi.org/10.1097/00000658-199903000-00020.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Van de Wiele, Christophe, Christophe Lahorte, Wim Oyen, Otto Boerman, Ingeborg Goethals, Guido Slegers, and Rudi Andre Dierckx. "Nuclear medicine imaging to predict response to radiotherapy: a review." International Journal of Radiation Oncology*Biology*Physics 55, no. 1 (January 2003): 5–15. http://dx.doi.org/10.1016/s0360-3016(02)04122-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Gluckman, Jack L. "Thyroid disease: endocrinology, surgery, nuclear medicine, and radiotherapy (ed 2)." American Journal of Otolaryngology 19, no. 3 (May 1998): 220–21. http://dx.doi.org/10.1016/s0196-0709(98)90094-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Radiotherapy and Nuclear Medicine"

1

COSTA, ALESSANDRO M. da. "Metodos de calibracao e de intercomparacao de calibradores de dose utilizados em servicos de medicina nuclear." reponame:Repositório Institucional do IPEN, 1999. http://repositorio.ipen.br:8080/xmlui/handle/123456789/10713.

Full text
Abstract:
Made available in DSpace on 2014-10-09T12:43:16Z (GMT). No. of bitstreams: 0
Made available in DSpace on 2014-10-09T13:56:47Z (GMT). No. of bitstreams: 1 06482.pdf: 3797240 bytes, checksum: 7b50be56353dab12e0bedb2f4d9c3488 (MD5)
Dissertacao (Mestrado)
IPEN/D
Instituto de Pesquisas Energeticas e Nucleares - IPEN/CNEN-SP
APA, Harvard, Vancouver, ISO, and other styles
2

Massicano, Felipe. "Modelagem de um sistema de planejamento em radioterapia e medicina nuclear com o uso do código MCNP6." Universidade de São Paulo, 2015. http://www.teses.usp.br/teses/disponiveis/85/85133/tde-11032016-093447/.

Full text
Abstract:
O tratamento de câncer possui diversas modalidades. Uma delas é a utilização de fontes de radiação como principal protagonista do tratamento. A radioterapia e a medicina nuclear são exemplos desse tipo de tratamento. Por utilizarem a radiação ionizante como principal ferramenta para a terapia, há a necessidade de se efetuar diversas simulações do tratamento a fim de maximizar a dose nos tecidos tumorais sem ultrapassar os limites de dose nos tecidos sadios circunvizinhos. Os sistemas utilizados na simulação desses tipos de terapia recebem o nome de Sistemas de Planejamento Dosimétrico. A medicina nuclear e a radioterapia possuem seus próprios sistemas de planejamento dosimétricos devido a grande diversidade das informações necessárias às suas simulações. Os sistemas de planejamento em radioterapia são mais consolidados do que os de medicina nuclear e por tal motivo um sistema que aborde tanto os casos de radioterapia como de medicina nuclear contribuiria para significativos avanços na área de medicina nuclear. Dessa forma, o objetivo do trabalho foi modelar um Sistema de Planejamento Dosimétrico com o uso do código de Monte Carlo MCNP6 Monte Carlo N-Particle Transport Code que permitisse incorporar os casos de radioterapia e medicina nuclear e que fosse extensível a novos tipos de tratamentos. A modelagem desse sistema resultou na construção de um Framework, orientado a objetos, nomeado IBMC o qual auxilia no desenvolvimento de sistemas de planejamento que necessitam interpretar grandes quantidades de informações com o objetivo de escrever o arquivo base do MCNP6. O IBMC permitiu desenvolver de maneira rápida e prática sistemas de planejamento para radioterapia e medicina nuclear e os resultados foram validados com sistemas já consolidados. Ele também mostrou alto potencial para desenvolver sistemas de planejamento de novos tipos de tratamentos que utilizam a radiação ionizante.
Cancer therapy has many branches and one of them is the use of radiation sources as treatment leading method. Radiotherapy and nuclear medicine are examples of these treatment types. For using the ionization radiation as main tool for the therapy, there is the need of crafting many treatment simulation in order to maximum the tumoral tissue dose without throught the dose limit in health tissue surrounding. Treatment planning systems (TPS) are systems which have the purpose of simulating these therapy types. Nuclear medicine and radiotherapy have many distinct features linked to the therapy mode and consequently they have different TPS destined for each. The radiotherapy TPS is more developed than the nuclear medicine TPS and by that reason the development of a TPS that was similar to the radiotherapy TPS, but enough generic for include other therapy types, it will contribute with significant advances in nuclear medicine and in others therapy types with radiation. Based on this, the goal of work was to model a TPS that utilizes the Monte Carlo N-Particle Transport code (MCNP6) in order to simulate radiotherapy therapy, nuclear medicine therapy and with potential for simulating other therapy types too. The result of this work was the creation of a Framework in Java language, objectoriented, named IBMC which will assist in the development of new TPS with MCNP6 code. The IBMC allowed to develop rapidly and easily TPS for radiotherapy and nuclear medicine and the results were validated with systems already consolidated. The IBMC showed high potential for developing TPS by new therapy types.
APA, Harvard, Vancouver, ISO, and other styles
3

Adjeiwaah, Mary. "Quality assurance for magnetic resonance imaging (MRI) in radiotherapy." Licentiate thesis, Umeå universitet, Institutionen för strålningsvetenskaper, 2017. http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-142603.

Full text
Abstract:
Magnetic resonance imaging (MRI) utilizes the magnetic properties of tissues to generate image-forming signals. MRI has exquisite soft-tissue contrast and since tumors are mainly soft-tissues, it offers improved delineation of the target volume and nearby organs at risk. The proposed Magnetic Resonance-only Radiotherapy (MR-only RT) work flow allows for the use of MRI as the sole imaging modality in the radiotherapy (RT) treatment planning of cancer. There are, however, issues with geometric distortions inherent with MR image acquisition processes. These distortions result from imperfections in the main magnetic field, nonlinear gradients, as well as field disturbances introduced by the imaged object. In this thesis, we quantified the effect of system related and patient-induced susceptibility geometric distortions on dose distributions for prostate as well as head and neck cancers. Methods to mitigate these distortions were also studied. In Study I, mean worst system related residual distortions of 3.19, 2.52 and 2.08 mm at bandwidths (BW) of 122, 244 and 488 Hz/pixel up to a radial distance of 25 cm from a 3T PET/MR scanner was measured with a large field of view (FoV) phantom. Subsequently, we estimated maximum shifts of 5.8, 2.9 and 1.5 mm due to patient-induced susceptibility distortions. VMAT-optimized treatment plans initially performed on distorted CT (dCT) images and recalculated on real CT datasets resulted in a dose difference of less than 0.5%.  The magnetic susceptibility differences at tissue-metallic,-air and -bone interfaces result in local B0 magnetic field inhomogeneities. The distortion shifts caused by these field inhomogeneities can be reduced by shimming.  Study II aimed to investigate the use of shimming to improve the homogeneity of local  B0 magnetic field which will be beneficial for radiotherapy applications. A shimming simulation based on spherical harmonics modeling was developed. The spinal cord, an organ at risk is surrounded by bone and in close proximity to the lungs may have high susceptibility differences. In this region, mean pixel shifts caused by local B0 field inhomogeneities were reduced from 3.47±1.22 mm to 1.35±0.44 mm and 0.99±0.30 mm using first and second order shimming respectively. This was for a bandwidth of 122 Hz/pixel and an in-plane voxel size of 1×1 mm2.  Also examined in Study II as in Study I was the dosimetric effect of geometric distortions on 21 Head and Neck cancer treatment plans. The dose difference in D50 at the PTV between distorted CT and real CT plans was less than 1.0%. In conclusion, the effect of MR geometric distortions on dose plans was small. Generally, we found patient-induced susceptibility distortions were larger compared with residual system distortions at all delineated structures except the external contour. This information will be relevant when setting margins for treatment volumes and organs at risk.   The current practice of characterizing MR geometric distortions utilizing spatial accuracy phantoms alone may not be enough for an MR-only radiotherapy workflow. Therefore, measures to mitigate patient-induced susceptibility effects in clinical practice such as patient-specific correction algorithms are needed to complement existing distortion reduction methods such as high acquisition bandwidth and shimming.
APA, Harvard, Vancouver, ISO, and other styles
4

MASSICANO, FELIPE. "Modelagem de um sistema de planejamento em radioterapia e medicina nuclear com o uso do código MCNP6." reponame:Repositório Institucional do IPEN, 2015. http://repositorio.ipen.br:8080/xmlui/handle/123456789/26371.

Full text
Abstract:
Submitted by Claudinei Pracidelli (cpracide@ipen.br) on 2016-06-22T11:21:31Z No. of bitstreams: 0
Made available in DSpace on 2016-06-22T11:21:31Z (GMT). No. of bitstreams: 0
Tese (Doutorado em Tecnologia Nuclear)
IPEN/T
Instituto de Pesquisas Energeticas e Nucleares - IPEN-CNEN/SP
APA, Harvard, Vancouver, ISO, and other styles
5

Shortkroff, Sonya. "The influence of radionuclides on synovitis and its assessment by MRI." Thesis, University of Bristol, 2000. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.326039.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

COSTA, ALESSANDRO M. da. "Desenvolvimento de camaras de ionizacao Tandem para utilizacao em programas de controle da qualidade em radioterapia e radiodiagnostico." reponame:Repositório Institucional do IPEN, 2003. http://repositorio.ipen.br:8080/xmlui/handle/123456789/11103.

Full text
Abstract:
Made available in DSpace on 2014-10-09T12:48:23Z (GMT). No. of bitstreams: 0
Made available in DSpace on 2014-10-09T13:57:11Z (GMT). No. of bitstreams: 1 08715.pdf: 4323271 bytes, checksum: 6c93cac5d8cfc34b7d3a208547cb8f8d (MD5)
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Tese (Doutoramento)
IPEN/T
Instituto de Pesquisas Energeticas e Nucleares - IPEN/CNEN-SP
FAPESP:98/14763-4
APA, Harvard, Vancouver, ISO, and other styles
7

Vouche, Michael. "Radiation Segmentectomy, Radiation Lobectomy and Response Assessment after 90Yttrium Radioembolization for Hepatocellular carcinoma: Imaging and Clinical Implications." Doctoral thesis, Universite Libre de Bruxelles, 2017. http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/241979.

Full text
Abstract:
Hepatocellular carcinoma is a primary liver cancer.Among treatment options for hepatocellular carcinoma, Yttrium-90 radioembolization is a promising transarterial therapy.This thesis investigates potential clinical applications of radioembolization in the treatment of the hepatocellular carcinoma (techniques of radiation segmentectomy and radiation lobectomy), and adress the problematic of the response Assessment after radioembolization.
Doctorat en Sciences médicales (Médecine)
info:eu-repo/semantics/nonPublished
APA, Harvard, Vancouver, ISO, and other styles
8

Costa, Gustavo. "IRDose : un outil web de dosimétrie individualisée basé sur la méthode Monte Carlo pour les patients en thérapie avec le 177Lu." Thesis, Toulouse 3, 2019. http://www.theses.fr/2019TOU30027.

Full text
Abstract:
La médecine nucléaire est une spécialité médicale qui utilise un radiopharmaceutique dont l'administration permet généralement de visualiser une fonction, en détectant les émissions gamma (γ) du radio-isotope vectorisé. Lorsque le but de cette pratique est la thérapie (radiothérapie moléculaire), on privilégie des isotopes qui émettent des radiation à courte portée (α, β ou électrons Auger). Les traitements utilisant 177Lu-DOTATATE ont obtenu leur autorisation de mise sur le marché (AMM) sur la base de l'administration de 7,4 GBq par cycle (activité fixe), sans tenir compte de la variabilité de fixation inter patient. Ceci entraîne une importante fluctuation de la dose absorbée délivrée aux organes à risque et aux cibles tumorales, et par conséquent, une grande difficulté à prédire les résultats du traitement. Des études récentes suggèrent que la planification basée sur une dosimétrie individuelle est une piste d'optimisation du traitement. L'objectif de ce travail est de participer au développement de la dosimétrie clinique en radiothérapie moléculaire, notamment par le développement d'un outil web dédié à la dosimétrie interne personnalisée de patients traités avec 177Lu et basé sur la méthode Monte-Carlo. Dans un premier temps, nous avons réalisé une étude sur la modélisation de systèmes SPECT avec le code Monte-Carlo GATE. L'optimisation des simulations a été réalisée par différentes méthodes pour réduire les temps de simulation. Ces techniques ont réduit le temps de simulation jusqu'à un facteur de 85. Certaines ont été utilisées dans la comparaison entre acquisitions tomographiques simulées et expérimentales. Cette comparaison a permis la modélisation du contexte expérimental utilisé dans la validation de l'outil web, Finalement, une page web a été conçue en utilisant le framework Django où une séquence de scripts en Python et Bash réalisent le calcul de la dose absorbée par simulation avec GATE. Les doses absorbée obtenues ont été comparées avec OLINDA (version 1 et 2). Nos résultats montrent des différences entre 0,3% et 6,1%, selon la version d'OLINDA
Nuclear medicine is a medical specialty that uses a radiopharmaceutical whose administration generally allows to visualize an organ function by detecting the gamma (γ) emissions of the targeted radioisotope. When the goal of this practice is molecular radiotherapy, isotopes emitting short-range radiation (α, β or electron Augers) are preferred. In general, treatments using 177Lu-DOTATATE still uses the historical practice of a fixed administration of 7.4 GBq per cycle, regardless the sex, age or inter-patient fixation variability. This causes a large fluctuation of the absorbed dose delivered to organs at risk and tumour targets, and therefore a great difficulty in predicting the treatment results. Recent studies suggest that treatment planning based on individual dosimetry is a way to optimize the treatment. The objective of this work is to contribute to the development of clinical dosimetry in molecular radiotherapy, in particular by developing a web tool based on the Monte Carlo method GATE dedicated to individualised internal dosimetry of patients treated with 177Lu. First of all, a study on the modelling of the SPECT systems by the Monte Carlo toolkit, GATE was realized, as well as the optimization of these simulations, where different methods were used in order to reduce simulation time. These techniques reduced simulation time by up to 85, and some of them were used in the comparison between simulated and experimental tomographic acquisitions. This comparison allowed the modelling of an experimental context which was used for the web tool validation. Finally, the web page was designed using the Django framework where a sequence of scripts in Python and Bash perform the calculation of the absorbed dose by GATE simulations. The absorbed doses obtained were compared with OLINDA versions 1 and 2, and the results show differences between 0.3% and 6.1%, depending on OLINDA's version
APA, Harvard, Vancouver, ISO, and other styles
9

MARTINS, ELAINE W. "Desenvolvimento e aplicação de um simulador pediátrico craniano para dosimetria em tomografia computadorizada." reponame:Repositório Institucional do IPEN, 2016. http://repositorio.ipen.br:8080/xmlui/handle/123456789/26608.

Full text
Abstract:
Submitted by Marco Antonio Oliveira da Silva (maosilva@ipen.br) on 2016-08-26T10:42:03Z No. of bitstreams: 0
Made available in DSpace on 2016-08-26T10:42:03Z (GMT). No. of bitstreams: 0
Para avaliar os níveis de exposição e a dose absorvida em pacientes submetidos a exames de tomografia computadorizada, TC, é necessário calcular os índices de dose em medições com um simulador de PMMA, ou cheio de água. O simulador deve ser capaz de reproduzir as características de absorção e espalhamento do corpo ou parte do corpo humano em um campo de radiação. As grandezas específicas em TC: índice de kerma livre no ar (Ca,100), índice de kerma no ar ponderado (CW), índice de kerma no volume total (Cvol) e produto kerma no ar-comprimento (PKL) devem ser determinadas e comparadas com os níveis de referência já existentes na literatura. Neste trabalho foi desenvolvido um simulador pediátrico craniano, já que no Brasil os níveis de referência para diagnósticos (NRDs) disponíveis foram determinados baseados em um simulador padrão adulto. O simulador desenvolvido inovou em sua construção apresentando materiais que simulam a calota craniana em osso cortical (alumínio) e osso esponjoso (PVC). O seu interior foi preenchido com água destilada. As dimensões foram escolhidas de acordo com as recomendações da Organização Mundial da Saúde e do International Commission on Radiation Units, para o tamanho da cabeça de uma criança de 0 a 5 anos: 160 mm de diâmetro e 155 mm de altura. A calota craniana tem uma espessura de 4 mm e diâmetro interno de 111,9 mm. Para avaliar seu comportamento foram realizados testes em laboratórios e em feixes clínicos. Os resultados apresentaram uma atenuação de até 23% na utilização dos materiais que simulam a calota craniana evidenciando que os valores adotados para os cálculos de NRD podem estar superestimando a dose recebida por pacientes pediátricos. Percebe-se que a dose recebida em exames de crânio apresenta uma distribuição diferente por ser parcialmente atenuada e/ou retroespalhada pela calota craniana, o que não é considerado ao se utilizar o simulador constituído apenas de PMMA.
Tese (Doutorado em Tecnologia Nuclear)
IPEN/T
Instituto de Pesquisas Energéticas e Nucleares - IPEN-CNEN/SP
APA, Harvard, Vancouver, ISO, and other styles
10

Sjögren, Adam. "The impact of metallic cranial implants on proton-beam radiotherapy treatment plans for near implant located tumours : A phantom study on the physical effects and agreement between simulated treatment plans and the resulting treatment for near implant located cranial tumours." Thesis, Umeå universitet, Institutionen för fysik, 2018. http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-149530.

Full text
Abstract:
Within the field of radiotherapy treatments of tumour diseases, the hunt for more accurate and effective treatment methods is a continuous process. For some years ion-beam based radiotherapy, especially the proton-beam based applications, has increased in popularity and availability. The main reason behind this is the fact that ion-beam based applications make it possible to modulate the dose after the planning target volume (PTV) defined by the radiation oncologist. This means that it becomes possible to spare tissue in another way, which might result in more effective treatments, especially in the vicinity of radio sensitive organs. Ion-beam based treatments are however more sensitive to uncertainties in PTV position and beam range as ion-beams have a fixed range depending on target media and initial energy, as opposed to the conventional x-ray beams that do not really have a defined range. Instead their intensity decreases exponentially at a rate dependent of the initial energy and target media. Therefore density heterogeneities result in uncertainties in the planned treatments. As the plans normally are created using a CT-images, for which metallic implants can yield increased heterogeneities both from the implants themselves and so called metal artifacts (distortions in the images caused by different processes as the X-rays used in image acquisition goes through metals). Metallic implants affects the accuracy of a treatment, and therefore also the related risks, so it is important to have an idea of the magnitude of the impact. Therefore the aim of this study is to estimate the impact on a proton-beam based treatment plan for six cranial implants. These were one Ti-mesh implant, one temporal plate implant, one burr-hole cover implant and three craniofix implants of different sizes, which all are commonly seen at the Skandion clinic. Also the ability of the treatment planning system (TPS), used at the clinic, to simulate the effects on the plans caused by the implants is to be studied. From this result it should be estimated if the margins and practices in place at the clinic, for when it is required to aim the beam through the implant, are sufficient or if they should be changed. This study consisted of one test on the range shift effects and one test on the lateral dose distribution changes, with one preparational test in the form of a calibration of Gafchromic EBT3 films. The range shift test was performed on three of the implants, excluding the three craniofix implants using a water phantom and a treatment plan created to represent a standard treatment in the cranial area. The lateral dose distribution change test was performed as a solid phantom study using radiochromic film, for two treatment plans (one where the PTV was located \SI{2}{\centi\metre} below surface, for all implants, and one where it was located at the surface, only for the Ti-mesh and the temporal plate). The results of both tests were compared to simulations performed in the Eclipse treatment planing system (TPS) available at Skandion. The result of the range shift test showed a maximum range shift of \SI{-1.03 +- 0.01}{\milli\metre}, for the burr-hole cover implant, and as the related Eclipse simulations showed a maximal shift of \SI{-0.17 +- 0.01}{\milli\metre} there was a clear problem with the simulation. However, this might not be because of the TPS but due to errors in the CT-image reconstruction, such as, for example, geometrical errors in the representation of the implants. As the margin applied for a similar situation at the Skandion clinic (in order to correct for several uncertainty factors) is \SI{4.2}{\milli\metre} there might be a need to increase this margin depending on the situation. For the lateral distribution effects no definite results were found as the change varied in magnitude, even if it tended to manifest as a decreasing dose for the first plan and a increasing dose for the second. It was therefore concluded that further studies are needed before anything clear can be said.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Radiotherapy and Nuclear Medicine"

1

Bleehen, Norman M. Radiobiology in Radiotherapy. London: Springer London, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

1920-, Robertson James S., and Held Kathryn D, eds. Nuclear medicine therapy. New York: Thieme Medical Publishers, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

J, Guiberteau Milton, ed. Essentials of nuclear medicine imaging. 6th ed. Philadelphia, PA: Elsevier/Saunders, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

service), SpringerLink (Online, ed. Fundamentals of Nuclear Pharmacy. 6th ed. New York, NY: Springer Science+Business Media, LLC, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Fundamentals of nuclear medicine dosimetry. New York: Springer, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Volterrani, Duccio. Fondamenti di medicina nucleare: Tecniche e applicazioni. Milano: Springer-Verlag Milan, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Dobbs, Jane. Practical radiotherapy planning. 3rd ed. London: Edward Arnold, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Barber, D. E. Radiation safety issues related to radiolabeled antibodies. Washington, DC: Division of Regulatory Applications, Office of Nuclear Regulatory Research, U.S. Nuclear Regulatory Commission, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Faggioni, Lorenzo. Elementi di tomografia computerizzata. Milano: Springer-Verlag Milan, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

International Commission on Radiological Protection. Protection of the patient in nuclear medicine: A report of a Task Group of Committee 3 of the International Commission on Radiological Protection. Oxford: Published for the ICRP by Pergamon Press, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Radiotherapy and Nuclear Medicine"

1

Nestle, Ursula. "PET for Radiotherapy Planning." In Therapeutic Nuclear Medicine, 879–90. Berlin, Heidelberg: Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/174_2012_689.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Hickman, Ray, and Martin Caon. "Nuclear Physics in Radiotherapy and Nuclear Medicine." In Nursing Science, 373–405. London: Macmillan Education UK, 1995. http://dx.doi.org/10.1007/978-1-349-15188-2_14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Schaefer, Niklaus. "Selective Internal Radiotherapy (SIRT) of Primary Hepatic Carcinoma and Liver Metastases." In Nuclear Medicine Therapy, 101–12. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-17494-1_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Gaze, Mark N., Jennifer E. Gains, and Jamshed B. Bomanji. "Current Issues in Molecular Radiotherapy in Children." In Clinical Nuclear Medicine in Pediatrics, 29–49. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-21371-2_3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Panyutin, Igor G., Thomas A. Winters, Ludwig E. Feinendegen, and Ronald D. Neumann. "Development of DNA-based Radiopharmaceuticals Carrying Auger-Electron Emitters for Anti-gene Radiotherapy." In Molecular Nuclear Medicine, 697–712. Berlin, Heidelberg: Springer Berlin Heidelberg, 2003. http://dx.doi.org/10.1007/978-3-642-55539-8_29.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Christofides, S., L. Malone, S. Mattsson, and P. Horton. "Criteria for Acceptability for Radiological, Nuclear Medicine and Radiotherapy Equipment – Part 4: Nuclear Medicine Equipment." In IFMBE Proceedings, 53–55. Berlin, Heidelberg: Springer Berlin Heidelberg, 2009. http://dx.doi.org/10.1007/978-3-642-03902-7_16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Horton, P., I. L. Lamm, W. Lehmann, and S. Lillicrap. "Criteria for Acceptability for Radiological, Nuclear Medicine and Radiotherapy Equipment – Part 3: Radiotherapy Equipment." In IFMBE Proceedings, 56–57. Berlin, Heidelberg: Springer Berlin Heidelberg, 2009. http://dx.doi.org/10.1007/978-3-642-03902-7_17.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Malone, J. F., A. Schreiner, H. Zoetelief, I. D. Mclean, S. Balter, E. Vano, H. Bosmans, et al. "Criteria for Acceptability for Radiological, Nuclear Medicine and Radiotherapy Equipment – Part 2: Radiology Equipment." In IFMBE Proceedings, 211–14. Berlin, Heidelberg: Springer Berlin Heidelberg, 2009. http://dx.doi.org/10.1007/978-3-642-03902-7_60.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Faulkner, K., J. Malone, S. Christofides, and S. Lillicrap. "Criteria for Acceptability for Radiological, Nuclear Medicine and Radiotherapy Equipment – Part 1: Introduction and Methodology." In IFMBE Proceedings, 85–88. Berlin, Heidelberg: Springer Berlin Heidelberg, 2009. http://dx.doi.org/10.1007/978-3-642-03902-7_25.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Vergnon, Jean-Michel, and Jean-Paul Homasson. "Cryotherapy — Radiotherapy." In Cryotherapy in Chest Medicine, 85–90. Paris: Springer Paris, 1992. http://dx.doi.org/10.1007/978-2-8178-0880-2_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Radiotherapy and Nuclear Medicine"

1

Wilkens, Jan J., Carlos Granja, Claude Leroy, and Ivan Stekl. "Introduction to Radiotherapy with Photon and Electron Beams and Treatment Planning from Conformal Radiotherapy to IMRT." In Nuclear Physics Medthods and Accelerators in Biology and Medicine. AIP, 2007. http://dx.doi.org/10.1063/1.2825834.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Akbar, Sajjad, M. Shahid Khalil, and Shahzad Ahmad. "Protection and Monitoring of Ionizing Radiation - Nuclear Medicine." In 17th International Conference on Nuclear Engineering. ASMEDC, 2009. http://dx.doi.org/10.1115/icone17-75227.

Full text
Abstract:
The advancement in technology has resulted into development of Telethrapy and X-ray machine which has high potential hazards of ionizing radiation to user and patient exposed. Ionizing radiations are referred as gamma rays photons. X-rays can cause conjunctivitis and sterility. Ionization radiation is hazard both in radiotherapy and nuclear medicine department. The energy of this radiation is around 10eV, higher the energy of radiation greater is hazard because of penetration into tissues the basic protection rule is either move way from source of radiation or put absorber in between. These equipments are tools of diagnostics, therefore international commission on radiological protection (ICRP) ha recommended that exposure to radiation be kept minimum. Designing of teletherapy facilities play important role in protection and monitoring of radiations. The author has analyzed the protective measures and monitoring of radiations in various hospitals in public and private sector in Rawalpindi / Islamabad Pakistan. It has been observed that only in military hospitals strict protective and monitoring measurers are taken against radiations but in other public and private sector hospitals such measure are compromised due to lack of proper awareness. Pakistan nuclear regulatory authority (PNRA) is taking measures for ensuring protective and monitoring measurer against radiations and arousing awareness to all concerns.
APA, Harvard, Vancouver, ISO, and other styles
3

Pogue, Brian W. "Novel Optical Contrast in Cancer: Cherenkov radiation in radiotherapy and in nuclear medicine." In Cancer Imaging and Therapy. Washington, D.C.: OSA, 2016. http://dx.doi.org/10.1364/cancer.2016.jm4a.1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Bajusová, Alica, Gabriel Králik, Marcel Miglierini, Carlos Granja, and Claude Leroy. "Means of Intensity Modulation of Radiation in External Radiotherapy." In NUCLEAR PHYSICS METHODS AND ACCELERATORS IN BIOLOGY AND MEDICINE: Fifth International Summer School on Nuclear Physics Methods and Accelerators in Biology and Medicine. AIP, 2010. http://dx.doi.org/10.1063/1.3295644.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Fotina, I., J. Bogner, D. Georg, K. Poljanc, Carlos Granja, Claude Leroy, and Ivan Stekl. "On the Commissioning of CT-simulation in Radiotherapy Treatment Planning: A Phantom Study." In Nuclear Physics Medthods and Accelerators in Biology and Medicine. AIP, 2007. http://dx.doi.org/10.1063/1.2825804.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Dufek, Vladimir, Ivana Horakova, Leos Novak, Ondrej Koncek, Vit Richter, Lenka Janeckova, Carlos Granja, and Claude Leroy. "Evaluation of Patient Doses from Verification Techniques in Image-Guided Radiotherapy (IGRT)." In NUCLEAR PHYSICS METHODS AND ACCELERATORS IN BIOLOGY AND MEDICINE: Fifth International Summer School on Nuclear Physics Methods and Accelerators in Biology and Medicine. AIP, 2010. http://dx.doi.org/10.1063/1.3295647.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Eremenko, D. O., O. V. Fotina, T. V. Pankratova, S. Yu Platonov, E. B. Sirotkina, E. A. Subbotina, O. A. Yuminov, A. V. Tultaev, Carlos Granja, and Claude Leroy. "Preliminary Assessment of the Functional Fitness of Alpha Emitter At-211 for Radiotherapy." In NUCLEAR PHYSICS METHODS AND ACCELERATORS IN BIOLOGY AND MEDICINE: Fifth International Summer School on Nuclear Physics Methods and Accelerators in Biology and Medicine. AIP, 2010. http://dx.doi.org/10.1063/1.3295650.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Wegierek-Ciuk, Aneta, Anna Lankoff, Halina Lisowska, Anna Banasik-Nowak, Michał Arabski, Piotr Kedzierawski, Agnieszka Florek, Andrzej Wojcik, Carlos Granja, and Claude Leroy. "Chromosomal Radiosensitivity in Lymphocytes of Cervix Cancer Patients—Correlation with Side Effect after Radiotherapy." In NUCLEAR PHYSICS METHODS AND ACCELERATORS IN BIOLOGY AND MEDICINE: Fifth International Summer School on Nuclear Physics Methods and Accelerators in Biology and Medicine. AIP, 2010. http://dx.doi.org/10.1063/1.3295663.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

De Jesús, M., F. E. Trujillo-Zamudio, Maria-Ester Brandan, Flora Herrera-Martinez, Veronica Ramírez-R., and Mercedes Rodriguez-Villafuerte. "Radiotherapy and Nuclear Medicine Project for an Integral Oncology Center at the Oaxaca High Specialization Regional Hospital." In ELEVENTH MEXICAN SYMPOSIUM ON MEDICAL PHYSICS. AIP, 2010. http://dx.doi.org/10.1063/1.3531606.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Dash, S., A. Goel, and S. Sogani. "Incremental Role of 18F-FDG PET with contrast enhanced CT (PET-CECT) in detection of recurrence of carcinoma cervix." In 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685260.

Full text
Abstract:
Purpose: To evaluate the role of 18F-FDG PET with contrast enhanced CT (PET-CECT) in early detection of recurrence in follow up patients of carcinoma cervix. Methods: Patients with histopathologically proven carcinoma cervix who underwent chemotherapy, radiotherapy and/or surgery and on follow up were recruited in the study. Fifty-two patients underwent 18F-FDG PET-CECT for detection of recurrence. The median age was 51.5 (average = 53.4) years. PET-CECT studies were evaluated and analyzed separately by an experienced nuclear medicine physician and a radiologist independently. The physicians were blinded for the patient history. PET-CECT results were validated with histopathological correlation, conventional radiologic imaging/follow up PET-CECT study and clinical follow up. Results: Out of 52 patients, 34 patients were reported as positive for recurrence, 17 of these were having active local recurrence and 31 patients had regional lymph nodal metastases, 14 patients had distant metastases (out of them 6 patients had distant lymph node metastases, 6 had pulmonary metastases, 4 had skeletal metastases and two had liver metastases). Remaining 18 patients were reported as negative for recurrence. The lung was the most common site for distant metastasis. Patient were then further evaluated based on histopathological correlation, conventional radiologic imaging and follow up PET-CECT scan and five were found to be false positive and one patient was identified as false negative. The sensitivity, specificity, positive and negative predictive value were derived to be 96.7%, 77.3%, 85.3% and 94.4%, respectively. Accuracy was calculated to be 88.5%. Conclusions: 18F-FDG PET-CECT is a very useful non-invasive modality for the early detection of recurrence and metastatic workup in patients with carcinoma cervix with a very high sensitivity and negative predictive value. It is also useful in targeting biopsy sites in suspected cases of recurrence.
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Radiotherapy and Nuclear Medicine"

1

Knapp, Jr, F. (Cardiology and nuclear medicine). Office of Scientific and Technical Information (OSTI), October 1988. http://dx.doi.org/10.2172/6809693.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Bhat, M. R., and H. D. Lemmel. Data resources for nuclear medicine. Office of Scientific and Technical Information (OSTI), July 1995. http://dx.doi.org/10.2172/83873.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Wolf, W. (Radiopharmacokinetics: Utilization of nuclear medicine). Office of Scientific and Technical Information (OSTI), January 1989. http://dx.doi.org/10.2172/5402887.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Knapp, F. F. Jr. (Coordinated research programs in nuclear medicine). Office of Scientific and Technical Information (OSTI), October 1990. http://dx.doi.org/10.2172/6621014.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Miles N. Wernick. Final summary of "Future Directions in Nuclear Medicine". Office of Scientific and Technical Information (OSTI), December 2006. http://dx.doi.org/10.2172/896429.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Chadwick, M. B., D. T. L. Jones, and H. H. Barschall. Nuclear data for radiotherapy: Presentation of a new ICRU report and IAEA initiatives. Office of Scientific and Technical Information (OSTI), September 1998. http://dx.doi.org/10.2172/674723.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Horn, K. M., B. Doyle, M. N. Segal, R. W. Hamm, R. J. Adler, and E. Glatstein. The use of low energy, ion induced nuclear reactions for proton radiotherapy applications. Office of Scientific and Technical Information (OSTI), April 1995. http://dx.doi.org/10.2172/46659.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Wolf, W. [Radiopharmacokinetics: Utilization of nuclear medicine]. Comprehensive progress report, [1986--1989]. Office of Scientific and Technical Information (OSTI), December 1989. http://dx.doi.org/10.2172/10139218.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Knapp, F. F. Jr, K. R. Ambrose, A. P. Callahan, D. W. McPherson, S. Mirzadeh, A. Hasan, C. R. Lambert, and D. E. Rice. Nuclear Medicine Program progress report, quarter ending March 31, 1992. Office of Scientific and Technical Information (OSTI), July 1992. http://dx.doi.org/10.2172/7206392.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Knapp, Jr., F. F., K. R. Ambrose, M. M. Goodman, and P. C. Srivastava. Nuclear Medicine progress report for quarter ending March 31, 1986. Office of Scientific and Technical Information (OSTI), October 1986. http://dx.doi.org/10.2172/5020685.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Radiotherapy and Nuclear Medicine' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography